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Cortactin is an actin-binding protein that is overexpressed in many
cancers and is a substrate for both tyrosine and serine/threonine kinases.
Tyrosine phosphorylation of cortactin has been observed to increase cell
motility and invasion in vivo, although it has been reported to have both
positive and negative effects on actin polymerization in vitro. In contrast,
serine phosphorylation of cortactin has been shown to stimulate actin
assembly in vitro. Currently, the effects of cortactin serine phosphoryla-
tion on cell migration are unclear, and furthermore, how the distinct
phospho-forms of cortactin may differentially contribute to cell migration
has not been directly compared. Therefore, we tested the effects of
different tyrosine and serine phospho-mutants of cortactin on lamellipo-
dial protrusion, actin assembly within cells, and focal adhesion dynamics.
Interestingly, while expression of either tyrosine or serine phospho-
mimetic cortactin mutants resulted in increased lamellipodial protrusion
and cell migration, these effects appeared to be via distinct processes.
Cortactin mutants mimicking serine phosphorylation appeared to pre-
dominantly affect actin polymerization, whereas mutation of cortactin
tyrosine residues resulted in alterations in focal adhesion turnover. Thus
these findings provide novel insights into how distinct phospho-forms of
cortactin may differentially contribute to actin and focal adhesion dy-
namics to control cell migration.
cell migration; phosphorylation
CORTACTIN IS AN ACTIN-BINDING protein that is a major substrate
of v-Src in transformed cells and a regulator of actin dynamics
in response to various signaling pathways (6, 16). It is known
to participate in a wide variety of actin-based cellular processes
by supporting the regulated assembly of dynamic, branched
actin networks that act to push and deform cellular membranes
such as during lamellipodial protrusion or propulsion of vesi-
cles via actin comet tails (22, 31, 35). As a dynamic scaffolding
protein, cortactin contains multiple interactive domains that
bind to proteins involved in actin polymerization (see Fig. 1).
These include an NH2-terminal acidic domain that binds to and
activates the actin-related protein (Arp)2/3 complex (31) and a
COOH-terminal Src-homology 3 (SH3) domain that binds to,
among other proteins, the actin-regulatory protein neural Wiskott-
Aldrich syndrome protein (N-WASP) (18, 19). In addition,
cortactin contains a series of F-actin-binding domains and a
central domain rich in proline, serine, and threonine residues.
How complexes of cortactin and actin-regulatory proteins are
temporally assembled and localized to mediate actin polymeriza-
tion and support a complex process such as lamellipodial exten-
sion is not yet clear. However, the effects of cortactin on actin
assembly are thought to be regulated through phosphorylation of
cortactin by both tyrosine and serine/threonine kinases (6, 16, 35).
Src-mediated phosphorylation of tyrosine residues near the SH3
domain of cortactin has been implicated in altering actin organi-
zation, allowing for the disassembly of large cytoplasmic bundles
and subsequent formation of a finer lamellipodial meshwork that
may facilitate cell migration (11). Early studies indicated that
cortactin is also phosphorylated on serine/threonine residues (30,
36); indeed, cortactin has been demonstrated to be a substrate for
extracellular signal-regulated kinase (ERK) at two serine residues
present in the central domain of cortactin immediately upstream of
the Src-phosphorylated tyrosine residues (3, 18) (see Fig. 1).
Furthermore, phosphorylation of cortactin by ERK at these serine
residues has been suggested to alter its structural conformation,
resulting in an increased association with N-WASP and a marked
increase in actin polymerization. In contrast, Src-mediated ty-
rosine phosphorylation abolished the stimulatory effects of cor-
tactin on N-WASP-Arp2/3-induced actin polymerization (18).
However, a recent study by Tehrani et al. (28) revealed that when
the adaptor protein Nck1 was present along with N-WASP and
Arp2/3, tyrosine-phosphorylated cortactin had a positive effect on
the generation of actin filament barbed ends in vitro.
A current gap in our understanding of cortactin function is
an apparent disconnect between some of the observations made
using in vitro assays, such as the negative effects of Src-
mediated phosphorylation of cortactin on actin assembly, and
those made in living cells. For example, endothelial cells
overexpressing cortactin were observed to be exceptionally
motile, while migration of cells into a wound was inhibited in
cells expressing a cortactin mutant unable to be phosphorylated
on key tyrosine residues (11). Similarly, overexpression of
cortactin in breast cancer cells resulted in increased bone
metastasis when these cells were injected into a nude mouse
model, whereas injection of cells expressing a tyrosine phos-
pho-inhibitory cortactin mutant resulted in fewer bone metas-
tases as compared with the control group (14). Thus, the
functions of cortactin appear to be regulated in a complex
manner through phosphorylation at multiple sites. Indeed, a
recent mass spectrometry analysis of cortactin purified from
human embryonic kidney HEK-293 cells identified 17 new
sites of cortactin phosphorylation for a total of 22 sites (4
tyrosine, 14 serine, and 4 threonine) when combined with the
previously identified phosphorylation sites (17). However, the
functional implications of this differential phosphorylation on
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actin dynamics with relation to migration of living cells need to
be tested and compared.
Here, using the expression of phospho-mimetic and phos-
pho-inhibitory cortactin tyrosine and serine mutants in cultured
tumor cells and fibroblasts, we provide a detailed analysis of
the mechanisms by which serine and tyrosine phosphorylation
of cortactin may differentially contribute to cell migration.
Interestingly, while phosphorylation at either site promotes cell
migration, tyrosine phosphorylation appears to increase focal
adhesion dynamics and lead to stress fiber disassembly. In
contrast, serine phosphorylation of cortactin promotes the as-
sembly of extensive branched actin networks. Thus these
findings provide novel insights into how distinct types of
phosphorylation may differentially regulate the effects of cor-
tactin on specific processes to mediate cell migration and
metastasis.
MATERIALS AND METHODS
Cells. Human pancreatic tumor cells (HPAF-II, BxPC-3, and PANC-
1), rat fibroblasts (FR), and normal rat liver cells (Clone 9) were acquired
from American Type Culture Collection (Rockville, MD). Mouse em-
bryonic fibroblasts (MEFs) were a gift from Andra´s Kapus (University of
Toronto, Toronto, Canada). HPAF-II cells were maintained in EMEM
(Mediatech, Herndon, VA) supplemented with 0.1 mM nonessential
amino acids and 1 mM sodium pyruvate; BxPC-3 cells were maintained
in RPMI 1640 (Mediatech) supplemented with glutamine, 10 mM
HEPES, 4.5 mM glucose, and 1.5 mM sodium bicarbonate; PANC-1,
FR, and MEF cells were maintained in DMEM (Mediatech); and Clone
9 cells were maintained in Ham’s F12K medium (Mediatech). Media for
all cell lines contained 10% FBS, and 100 U/ml penicillin and 100 g/ml
streptomycin (Invitrogen, Carlsbad, CA). All cells were grown at 37°C in
5% CO2. Cells were cultured on normal or gridded acid-washed glass
coverslips.
Constructs, transfection, and other reagents. Cells were transfected
with the indicated constructs using either the Lipofectamine Plus Trans-
fection Reagent (Invitrogen) or Genejammer Transfection Reagent
(Stratagene, La Jolla, CA) according to the manufacturer’s instruc-
tions. The cDNA sequence corresponding to rat cortactin isoform B
(GenBank accession no. NM_021868) was used for generating wild-
type and phospho-mutant cortactin constructs. Generation of wild-
type red fluorescent protein (RFP)-tagged cortactin has been previ-
ously described (4). RFP-cortactin tyrosine and serine mutants were
generated on the basis of known tyrosine (11) and serine (3, 18)
phosphorylation sites using the Stratagene QuikChange Site-Directed
Mutagenesis kit (Stratagene). The Myc-tagged type 1 phosphatidyl-
inositol-4-phosphate 5-kinase- (PIP5K1) construct was a gift from
Laura M. Machesky (University of Birmingham, Birmingham, UK),
and the green fluorescent protein (GFP)-paxillin construct was a gift
from Christopher E. Turner (State University of New York, Syracuse,
NY). Monoclonal anti-paxillin antibody was from BD Biosciences
(San Jose, CA), monoclonal anti-vinculin antibody was from Sigma
(St. Louis, MO), and FITC-conjugated phalloidin and Alexa-
conjugated secondary antibodies were from Invitrogen. EGF was from
Invitrogen, and nocodazole was from Sigma.
Microscopy. Cells were processed for fluorescence microscopy as
previously described (10), except that cells were fixed with 4% formal-
dehyde and permeabilized with 0.1% Triton X-100 for 2 to 5 min,
depending on the cell type. ProLong (Invitrogen) antifade reagent was
used as mounting medium. Live imaging experiments were performed
using previously described conditions (21). Microscopy was performed
on a Zeiss Axiovert 200 epifluorescent microscope (Zeiss, Thornwood,
NJ). Digital images were acquired and analyzed using a cooled-CCD
Orca II camera (Hamamatsu Photonics, Hamamatsu City, Japan) and the
software program IPLab (Scanalytics, Fairfax, VA). All images were
processed using Adobe Photoshop software (Adobe Systems, Mountain
View, CA).
To analyze comets using electron microscopy, cells containing
PIP5K1-induced comets positive for RFP-tagged cortactin were first
identified using fluorescence microscopy. These cells were then pro-
cessed for electron microscopy analysis using standard procedures
and observed with a JEOL 1200 transmission electron microscope
(JEOL USA, Peabody, MA).
Lamellipodial protrusion. Transfected cells were plated on glass
coverslips and serum starved (0.2% FBS) for 16 h. Subsequently, cells
were either mock stimulated with carrier or stimulated with EGF (30
ng/ml) for 20 min, processed for fluorescence microscopy analysis,
and stained with FITC-conjugated phalloidin. The percentage of
transfected cells extending a lamellipodium was determined for each
condition.
Wound healing. Transfected PANC-1 cells were grown to conflu-
ency on gridded glass coverslips, serum starved (0.2% FBS) for 16 h,
and then wounded with a pipette tip. After thorough washing, low
serum medium was replaced with full serum medium, and the migra-
tion of cells into the wound was followed over a 14-h time period. At
time 0, multiple images of each slip were taken, focusing on the
coverslip grid. At regular time intervals afterward, images were taken
in the exact same locations using the grid as a reference to track the
migration of cells in the wound. Image integration was performed
using IPLab software, and individual fluorescent cells were tracked.
All fluorescent cells within a 100-m distance from the wound front
at time 0 were tracked. Approximately 20 cells were analyzed for each
condition. The total distance each cell traveled was measured, and
since under some conditions the cells traveled in aberrant pathways,
the net distance into the wound perpendicular to the wound front was
also measured.
Comet formation. FR cells were plated on glass coverslips and were
cotransfected with RFP-cortactin and Myc-PIP5K1 constructs.
Twenty-four hours after transfection, cells were processed for fluo-
rescence microscopy analysis, staining with FITC-conjugated phal-
loidin, or correlative electron microscopy analysis. Additionally,
transfected cells were plated in imaging dishes, and comets were
imaged in living cells via the RFP-cortactin in their tails.
Focal adhesion dynamics. Focal adhesion size and morphology
were assessed in fixed FR cells that had been allowed to spread for 6 h
on coverslips coated with 1 g/ml fibronectin (Calbiochem, San Diego,
CA) by staining with a monoclonal anti-paxillin antibody or on the basis
of GFP-paxillin signal.
To monitor focal adhesion turnover in living cells, MEFs and
PANC-1 cells were cotransfected with GFP-paxillin and RFP-cortac-
tin constructs. Twenty-four hours after transfection, cells were
trypsinized and resuspended in serum-containing medium. Subse-
quently, cells were replated on coverslips coated with 1 g/ml
fibronectin and allowed to spread for 30 min before being imaged
using either time-lapse confocal microscopy or total internal reflection
fluorescence (TIRF) microscopy.
Focal adhesion reassembly following microtubule-mediated focal
adhesion disassembly was assayed in MEFs and PANC-1 cells as
follows. First, cells were treated with 10 g/ml nocodazole for 3 h at
37°C to induce microtubule disassembly. The drug was then washed
out, and microtubules were allowed to repolymerize over various time
intervals. Subsequently, cells were fixed and processed for immuno-
fluorescence, staining with a monoclonal antibody against vinculin.
Cells were imaged using fluorescence microscopy, and the presence or
absence of focal adhesions was quantitated.
RESULTS
Cortactin phosphorylation promotes lamellipodial protru-
sion and cell migration. We have previously observed that
cortactin is present at both plasma membrane clathrin-coated
pits and the Golgi in cultured rat hepatocytes (Clone 9) (4, 5)
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(Fig. 1A), an epithelial cell type normally exhibiting a discoidal
cell shape. Interestingly, expression of a RFP-tagged version of
cortactin mutated to mimic Src-mediated phosphorylation (rat
cortactin isoform b Y384/429/445E; CortYE) in these cells
resulted in graphic changes in cell morphology. Even in the
absence of growth factor stimulation, Clone 9 cells expressing
CortYE appeared elongated and highly polarized, and extended
elaborate lamellipodia (Fig. 1B). These initial observations
made in nonmotile, normal epithelial cells provided a strong
incentive to test the effects of the different phospho-forms of
cortactin on growth factor-mediated induction of lamellipodial
extension and migration in inherently motile cell types, partic-
ularly cancer cells. Toward this end, we compared the effects
of tyrosine versus serine cortactin phospho-mutants on cell
migration, the assembly of actin structures in the confines of
living cells, and focal adhesion dynamics using cultured fibro-
blasts (MEFs and RF cells) and three human pancreatic ductal
carcinoma cell lines, BxPC-3 (27), PANC-1 (15), and HPAF-II
(12, 24). (For a graded comparison of these lines, see Ref. 26.)
In addition to generating the RFP-tagged cortactin mutant
mimicking Src-mediated phosphorylation (CortYE) indicated
above, cortactin phospho-mutants designed to inhibit (Y384/
429/445F; CortYF) Src-mediated phosphorylation, or inhibit
(S368/381A; CortSA) or mimic (S368/381D; CortSD) ERK-
mediated phosphorylation were constructed on the basis of
previously identified sites of tyrosine (11) and serine (3, 18)
phosphorylation. These mutants, RFP-tagged wild-type cortac-
tin (CortWT) or vector alone, were then expressed in BxPC-3
(Fig. 1, C–G) or HPAF-II cells (supplemental material Fig. S1;
the online version of this article contains supplemental data),
and the effects on the percentage of cells that formed lamelli-
podia in the absence and presence of EGF were quantitated. As
expected, EGF treatment resulted in an approximately 3.5-fold
stimulation of lamellipodial protrusion in vector- and CortWT-
expressing cells (Fig. 1H and supplemental Fig. S1F). Inter-
estingly, cells expressing the cortactin phospho-mimetic mu-
tants CortSD and CortYE exhibited an approximately 2.5- to
3-fold increase in the percentage of cells that extended lamel-
lipodia in the absence of EGF, as compared with control and
CortWT-expressing cells (Fig. 1H and supplementary Fig.
S1F; gray bars). Furthermore, this EGF-dependent extension of
lamellipodia was reduced in cells expressing the cortactin
Fig. 1. Expression of phospho-mimetic forms of cortactin in-
duces a dramatic motile phenotype in nonmigratory epithelial
cells and in pancreatic tumor cells. A cartoon of the cortactin
protein is shown with specific protein domains and sites of
serine (S) and tyrosine (Y) phosphorylation relevant to the
studies indicated. SH3, COOH-terminal Src-homology 3 do-
main; Arp, actin-related protein. A and B: fluorescence images
of cultured hepatocytes (Clone 9 cells) expressing red fluores-
cent protein (RFP)-tagged wild-type cortactin (CortWT; A) or
an RFP-tagged cortactin mutant mimicking tyrosine phosphor-
ylation (Y384/429/445E, CortYE; B). Clone 9 cells expressing
CortWT are discoidal in shape and exhibit a modest amount of
peripheral membrane ruffling (A). In contrast, expression of
CortYE in these cells induces marked changes in cell morphol-
ogy, as they become elongated and extend elaborate lamellipo-
dia (B). C–G: fluorescence images of BxPC-3 pancreatic tumor
cells that were transfected with either vector alone, as a control,
or RFP-tagged cortactin constructs (red), serum starved over-
night, and when indicated, treated with EGF (30 ng/ml) for 20
min. Subsequently, cells were processed for analysis by fluo-
rescence microscopy and were stained with FITC-conjugated
phalloidin (green) to label actin filaments. Cells expressing
CortWT extended lamellipodial protrusions under serum-
starved conditions (C, arrow) at a frequency similar to that of
cells expressing vector alone (data not shown), and this was
increased upon EGF treatment (D, arrow). Lamellipodial pro-
trusion (arrows) was increased by EGF treatment in untrans-
fected cells, but a cell expressing a cortactin mutant inhibiting
tyrosine phosphorylation (CortYF; E, arrowhead) shows virtu-
ally no lamellipod. Conversely, cells expressing cortactin mu-
tants mimicking either serine phosphorylation (CortSD; F) or
tyrosine phosphorylation (CortYE; G) frequently extended la-
mellipodia (arrows) even in the absence of EGF. H: graph
representing the percentage of cells expressing vector alone (V),
CortWT, or cortactin phospho-mutants that extended lamelli-
podia in the absence (gray bar) and presence (black bar) of
EGF. SA, cortactin mutant inhibiting serine phosphorylation.
Values represent the average SE for n  3 with 100 cells
counted for each condition. Bar, 10 m (A–G).
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phospho-inhibitory mutant CortYF. The baseline lamellipodial
formation seen in cells expressing the phospho-inhibitory
CortSA mutant may be attributed to the prolonged activation of
ERK caused by overexpression of cortactin as demonstrated by
Timpson et al. (29).
We next tested whether the increase in lamellipodial protru-
sion exhibited by the cortactin tyrosine and serine phospho-
mimetic mutants (CortSD and CortYE) may translate into
increased cell motility. We observed PANC-1 cells to be more
motile than HPAF-II or BxPC-3 cells (A. E. Kruchten, E. W.
Krueger, and M. A. McNiven, unpublished observations); thus,
wound-healing assays were performed using PANC-1 cells.
Expression of CortWT enhanced the migratory phenotype of
cells (Fig. 2, A and D), in agreement with previous reports that
overexpression of cortactin in fibroblasts and endothelial cells
enhances cell migration (11, 23). Similarly, cells expressing
CortSD or CortYE also exhibited an enhancement in cell migration,
although not above that of CortWT-expressing cells (Fig. 2, C and
D, and data not shown). In contrast, cells expressing CortSA or
CortYF migrated only approximately half as far as cells ex-
pressing CortWT or their respective phospho-mimetic mutant
(Fig. 2, B and D, and data not shown). Thus, both tyrosine and
serine phosphorylation of cortactin appear to be important not
only for lamellipodial protrusion, but also for the stimulatory
effects of cortactin on cell migration.
Serine phosphorylation of cortactin promotes actin assem-
bly in living cells. Similar to the branched actin network
formed at the leading edge of migrating cells, actin comets
used to propel some intracellular vesicles and pathogens also
exhibit a branched actin network (2, 9). Therefore, because it is
challenging to obtain quantitative measurements of actin as-
sembly at lamellipodia in living cells, we analyzed vesicle-
associated actin comet tails that are generated in cultured cells
(here, FR cells) upon overexpression of the lipid kinase type 1
phosphatidylinositol-4-phosphate 5-kinase- (PIP5K1; 20,
25). These comets are easily visualized and act to push vesicles
forward using an actin network also containing cortactin (20).
Thus we could readily quantify the number and dimensions of
actin comet tails formed behind vesicles in fixed or living cells
coexpressing Myc-tagged PIP5K1 and either wild-type or
phospho-mutants of RFP-tagged cortactin based on the fluo-
rescent cortactin incorporated into the tail and/or FITC-conju-
gated phalloidin, used to label actin. Most notably, in compar-
ison to the number of comets formed in cells expressing
CortWT (Fig. 3A) or CortSA (data not shown), CortSD-
expressing cells (Fig. 3C) showed a substantial increase in
comet number (2-fold; Fig. 3J), suggesting an increase in
actin polymerization. In contrast, expression of cortactin tyro-
sine mutants, either phospho-inhibitory (CortYF; Fig. 3B) or
phospho-mimetic (CortYE; data not shown), only slightly in-
creased the number of comets per cell in comparison to CortWT-
expressing cells (Fig. 3J).
Just as comet number can be used as an indicator of sites of
actin polymerization, the lengths and widths of individual actin
comet tails may also be representative of increased actin
branching and polymerization. The lengths of comet tails was
similar in cells expressing CortWT, CortYE, and CortSD,
possibly indicating that actin polymerization and branching
following nucleation is affected in a similar way by cortactin
tyrosine and serine phosphorylation. Indeed, comet tail length
was decreased in cells expressing either CortYF or CortSA, as
compared with CortWT- or cortactin phospho-mimetic-ex-
pressing cells (Fig. 3K). In contrast, comet tail width was
decreased in cells expressing CortYF or CortYE (Fig. 3L), but
it was increased in cells expressing CortSD (Fig. 3, D and L).
Interestingly, many of the comets generated in the CortSD-
expressing cells were so exceptionally thick as to appear
bifurcated and composed of two parallel, bright actin bundles
(Fig. 3D), a phenotype not observed in cells expressing
CortWT (Fig. 3D).
To confirm the differences in actin comet tail dimensions
observed in cells expressing the different cortactin phospho-
mutants at a higher resolution, comets were viewed using
electron microscopy (Fig. 3, E–I). In support of the fluores-
cence imaging, the shorter, thinner comets formed in the
CortSA-expressing cells exhibited an actin network that appeared to
surround only a small portion of the vesicle ( 30–40%; Fig. 3,
F and G), whereas in cells expressing CortSD, a larger portion of
the vesicle was surrounded by actin filaments (50–70%; Fig. 3,
H and I). In addition, the comet base was wider in cells
expressing CortSD, as compared with cells expressing CortSA.
Fig. 2. Tyrosine and serine phosphorylation of cortactin stimulates cell migration. Wound-healing assays were performed using PANC-1 pancreatic cancer cells
transfected with RFP-tagged cortactin constructs (red), and the movement of individual cells (colored lines) was tracked over a 14-h time period.
A–C: representative images and tracking of PANC-1 cells expressing CortWT (A), CortYF (B), or CortYE (C). Note the distance migrated by cells expressing
CortWT is markedly further than that of cells expressing CortYF. D: graph representing the distance traveled by cells expressing CortWT or cortactin
phospho-mutants. Values represent the average SD of 20 cells tracked for each condition over 18 frames. Statistically significant differences in distance
traveled were observed between CortWT and CortYF; CortWT and CortSA; and CortSA and CortSD (*P  0.05, by Student’s t-test), as well as when CortYF
is compared with either CortYE or CortSD (**P  0.01). Bar, 100 m (A–C).
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Tyrosine phosphorylation of cortactin alters focal adhe-
sion morphology and dynamics. Observation of actin comet
tails indicated that serine phosphorylation of cortactin pref-
erentially promotes actin assembly in cells; however, both
tyrosine and serine phospho-mimetic cortactin mutants pro-
mote lamellipodial protrusion and cell migration (Figs. 1
and 2 and supplemental Fig. S1). This paradox suggests that
Src-mediated tyrosine phosphorylation of cortactin may be
contributing to these dynamic processes in a way distinct
from actin assembly. Some insights into this possibility
come from a recent study showing that knockdown of
cortactin protein levels reduces the rate of focal adhesion
assembly (1) and our observation that some cells expressing
cortactin appear to exhibit prominent focal contact-like
structures (Fig. 6). Thus, because Src-mediated phosphory-
lation is known to play a role in regulating focal adhesion
dynamics (8, 34), we tested whether tyrosine phosphoryla-
tion of cortactin may contribute to lamellipodial protrusion
not by actin assembly at the leading edge, but by regulating
focal adhesion turnover.
First, focal adhesion size was analyzed in two different cell
types: FR cells, chosen because of the large adhesions made by
Fig. 3. Serine phosphorylation of cortactin increases the number, length, and caliber of PIP5K1-induced comets. Rat fibroblasts (FR cells) coexpressing
Myc-PIP5K1, to induce comet formation, and RFP-tagged wild-type or phospho-mutant cortactin were analyzed using fluorescence microscopy and electron
microscopy, quantitating the number of comets per cell and comet tail length and width. Comet tails were observed and measured by using the cortactin RFP
signal as a marker. A–C: cells expressing CortWT (A) or CortYF (B) had fewer and shorter comets than cells expressing CortSD (C). D and D: some of the
comets in the CortSD-expressing cells appeared to be substantially wider at the base (D), compared with comets in CortWT-expressing cells (D). E–I: electron
micrographs of PIP5K1-induced comets in cells expressing RFP-tagged CortWT (E, low magnification), CortSA (F and G, high magnification), or CortSD (H
and I, high magnification). The actin tails in CortSA-expressing cells (F and G) were narrower and did not extend as far around the lipid droplet as in
CortSD-expressing cells (H and I). J–L: graphs representing the number of fluorescent comets per living cell (J), comet tail length (K), and comet tail width (L)
in cells expressing CortWT or the various cortactin phospho-mutants. While the length of comet tails was increased both in CortYE- and CortSD-expressing cells,
comet tail thickness appeared to be increased more so in cells expressing CortSD. Values represent the average SE of 50 comets from at least 10 cells
analyzed for comet number and length for each condition (J and K), and of 55–115 comets from 6 to 8 cells analyzed for comet width for each condition (L).
Statistically significant differences in comet number (J) were observed between CortWT and CortSD; and CortSA and CortSD (P  0.05). Differences in comet
lengths (K) were not statistically significant. Statistically significant differences in comet widths (L) were observed between CortSD and CortYF; and CortSD
and CortYE (P  0.05). Bars, 1 m (E) and 0.5 m (F–I).
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these cells (Fig. 4A,A), and PANC-1 cells, which exhibit
smaller, more ephemeral adhesions (Fig. 4F,F). To mark focal
adhesions, cells were transfected to express RFP-tagged
CortWT or the cortactin phospho-mutants in combination with
GFP-tagged paxillin, a widely used marker for monitoring
focal adhesion dynamics (32, 34), or alternatively, cells were
stained with an anti-paxillin antibody. As shown in Fig. 4, FR
cells expressing CortYE exhibited small, sparsely populated
focal adhesions (Fig. 4B,B), compared with cells expressing
CortWT (Fig. 4A,A), whereas CortYF-expressing cells exhib-
ited much larger, more densely packed focal adhesions that
appeared to fill the cell border (Fig. 4C,C). Quantitation of
focal adhesion size in FR cells expressing wild-type cortactin
or the various cortactin phospho-mutants revealed a slight
reduction in size in cells expressing CortYE, CortSA, or
CortSD, as compared with CortWT-expressing cells, whereas
expression of CortYF resulted in an increase in focal adhesion
size (Fig. 4D). Indeed, a 2.5-fold difference in focal adhesion
size was determined in cells expressing CortYF versus
CortYE. While more difficult to quantitate, similar effects on
focal adhesion size were observed in PANC-1 tumor cells
expressing CortYE (Fig. 4G,G) and CortYF (Fig. 4H,H)
compared with cells expressing CortWT (Fig. 4F,F).
Changes in focal adhesion size could be a reflection of
changes in the dynamics of these structures. Therefore, focal
adhesion turnover was monitored in the context of CortWT,
CortYE, or CortYF expression by following the changes in
fluorescence intensity of GFP-paxillin over time in a localized
region on initiation of focal adhesion formation. For these
studies, MEFs expressing GFP-paxillin and RFP-tagged wild-
type or phospho-mutant cortactin were plated on coverslips
coated with 1 g/ml fibronectin and allowed to spread for 30
min before imaging of focal adhesions at the very base of cells
using TIRF microscopy. As shown by the line graph of repre-
sentative curves from individual MEFs, cells expressing
CortWT contained focal adhesions that assembled in 10–15
Fig. 4. Tyrosine phosphorylation of cortactin modulates focal adhesion size and stability. Focal adhesion size and dynamics were monitored in either FR cells,
mouse embryonic fibroblasts (MEFs), or PANC-1 cells expressing RFP-tagged wild-type or phospho-mutant cortactin. Green fluorescent protein (GFP)-paxillin
or staining with an anti-paxillin antibody was used as a marker for focal adhesions. A,A: a representative image of focal adhesions in an FR cell expressing
CortWT. B–C: focal adhesions in FR cells expressing CortYE (B,B) were much smaller than those in CortWT-expressing cells and composed of more discrete
GFP-paxillin puncta, whereas the focal adhesions in cells expressing CortYF (C,C) were markedly larger and more densely packed. D: graph representing
analysis of focal adhesion size in FR cells. A 2.5-fold difference exists between cells expressing CortYF versus those expressing CortYE. Values represent the
averageSE of10 FR cells analyzed for each condition. E: line graph of representative curves from individual MEFs expressing CortWT, CortYE, or CortYF,
indicating changes in GFP-paxillin fluorescence intensity, and thereby focal adhesion assembly and disassembly, over time. F–H: similar to FR cells, staining
of PANC-1 cells expressing the cortactin tyrosine phospho-mutants (CortYE, G,G; and CortYF, H,H) with an antibody against paxillin also revealed differences
in focal adhesion size, as compared with cells expressing CortWT (F,F). I: graph showing the amount of time required for focal adhesion (FA) assembly or
disassembly in PANC-1 cells expressing CortWT, CortYE, or CortYF. Values represent the average SE of approximately 6–8 PANC-1 cells analyzed for each
condition. J: line graph, similar to that shown in E; however, data from multiple PANC-1 cells were compiled to generate a single representative curve for each
condition (expression of CortWT, CortYE, or CortYF). Bar, 10 m (A–C and F–H); insets are higher magnifications of the respective boxed regions of paxillin
at focal adhesions.
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min and subsequently almost completely disassembled over the
following  5 min (Fig. 4E). Interestingly, CortYE-expressing
cells assembled and disassembled their small focal adhesions
much faster, as they both appeared and disassembled over an
15-min time period. In strong contrast, the large focal adhe-
sions present in CortYF-expressing cells assembled at a rate
similar to that of CortWT-expressing cells, but persisted at
70% of the peak GFP-paxillin fluorescence intensity beyond
30 min (Fig. 4E). PANC-1 cells demonstrated focal adhesion
dynamics similar to those of MEFs, with cells expressing
CortYF taking 1.5–2 times as long as CortWT-expressing
cells to assemble or disassemble focal adhesions (Fig. 4I).
Compilation of this focal adhesion assembly-disassembly data
from multiple PANC-1 cells into a single representative curve
for each condition (CortWT, CortYE or CortYF expression)
provides another way of depicting that focal adhesion dynam-
ics are slowed in PANC-1 cells expressing CortYF (Fig. 4J).
As a second method to assess a role for cortactin phosphor-
ylation in regulating focal adhesion size and turnover, we used
a microtubule-mediated focal adhesion disassembly assay sim-
ilar to that established by Ezratty et al. (7). Here, MEFs and
PANC-1 cells expressing wild-type or phospho-mutant cortac-
tin were treated with nocodazole to disassemble microtubules
and induce formation of focal adhesions. Subsequently, fol-
lowing washout of the drug, cells were allowed to recover for
2 h and were then stained for the focal adhesion marker
vinculin. During the first 60 min of the recovery period, 90%
of the focal adhesions are disassembled, possibly by an endo-
cytic mechanism (7), while focal adhesion reassembly occurs
during the second 60 min. It is predicted that ephemeral,
dynamic focal adhesions will not form as quickly during the
allotted recovery period, while stable adhesions will reassem-
ble more readily. Consistent with this premise, both MEFs and
PANC-1 cells expressing CortYE showed a marked decrease in
focal adhesion recovery (Fig. 5, A,A and C,C, respectively,
asterisks) compared with the CortWT- or CortYF-expressing
cells (Fig. 5, B,B and D,D, asterisks; and data not shown). In
contrast, focal adhesions in CortYF-expressing cells (Fig. 5,
B,B and D,D, asterisks) recovered more readily and were
noticeably larger than those in adjacent control cells as well as
those in the CortYE-expressing cells. Semiquantitative count-
ing of the number of focal adhesions in these cell populations
(Fig. 5E) suggested modest differences in focal adhesion reas-
sembly between cells expressing wild-type cortactin and either
of the cortactin tyrosine phospho-mutants, whereas a more
noticeable difference existed between cells expressing CortYE
versus CortYF.
Cortactin has been implicated in focal adhesion formation
(1), and our observations suggest that the different phospho-
forms of cortactin exert marked effects on focal adhesion size
and turnover in both normal and pancreatic tumor cells (Figs.
4 and 5). However, a direct localization of cortactin to these
Fig. 5. Expression of cortactin tyrosine phospho-mutants leads to distinct
effects on the ability of cells to reassemble focal adhesions. A–D: MEFs
(A–B) and PANC-1 cells (C–D) expressing wild-type or tyrosine phospho-
mutant cortactin (asterisks) were treated with nocodazole for 3 h to disassem-
ble microtubules and enhance formation of focal adhesions. Subsequently,
following drug washout, cells were allowed to recover for 2 h and were then
fixed and stained for vinculin (right). Additionally, cells were fixed and stained
in the absence of any recovery period (left). In untransfected cells, microtubule
regrowth induces focal adhesion disassembly in the first 60 min, followed by
focal adhesion reassembly over the next 60 min. In MEFs and PANC-1 cells
expressing CortYE (asterisks), focal adhesions were prominent before micro-
tubule regrowth (A and C, arrows) and disassembled in the initial 60-min
recovery period (data not shown). Following 120 min of recovery, although
focal adhesions had reassembled in surrounding untransfected cells (A and C,
arrows), focal adhesions did not readily reassemble in CortYE-expressing cells
(A and C, asterisks). MEFs and PANC-1 cells expressing CortYF (asterisks)
also displayed large focal adhesions before drug washout (B and D, arrows),
which disassembled upon microtubule regrowth (data not shown). In contrast
to cells expressing CortYE, however, CortYF-expressing cells appeared to
fully reassemble large focal adhesions over the 120-min recovery period (B
and D, arrows). E: graph representing the percentage of MEFs (gray bars) and
PANC-1 cells (black bars) expressing either wild-type or tyrosine phospho-
mutant cortactin that contained focal adhesions 2 h after washout of nocoda-
zole. Values represent the average SD for n  3 with 60 cells analyzed for
each condition. Bars, 8 m (A–D).
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structures in cells is lacking, suggesting that cortactin could be
affecting focal adhesions indirectly. As shown in Fig. 6, we
detected a marked localization of CortWT to the tips of actin
stress fibers in FR cells, which may represent sites of insertion
into focal adhesions (Fig. 6A,A, arrows). Indeed, subsequent
staining of cells with an antibody against paxillin confirmed
that the CortWT-positive structures were focal adhesions (Fig.
6B,B, arrows). As discussed below, the action of tyrosine-
phosphorylated cortactin on focal adhesion stability and turn-
over could have profound effects on actin stress fiber dynamics
and thereby markedly retard or accelerate cell migration.
DISCUSSION
The effects of tyrosine and serine/threonine phosphorylation
of cortactin on actin polymerization have been observed using
in vitro assays (18, 28), and these modifications are predicted
to play an important role in the regulation of actin dynamics in
living cells. Here, using expression of phospho-mutant forms
of cortactin in cells, we provide a detailed, quantitative exam-
ination of the physiological effects of phospho-cortactin on
actin-mediated processes in different pancreatic tumor cell
types and fibroblasts. Incorporation of a variety of assays in our
current study has allowed us to make significant observations
regarding the mechanisms by which distinct forms of cortactin
phosphorylation may regulate cell migration. Namely, al-
though both tyrosine and serine phosphorylation of cortactin
support lamellipodial extension and cell migration (Figs. 1 and
2 and supplemental Fig. S1), serine-phosphorylated cortactin
may do so by promoting the assembly of dendritic actin
networks (Fig. 3), while tyrosine phosphorylation of cortactin
appears to regulate focal adhesion dynamics (Figs. 4 and 5; see
cartoon, Fig. 6C).
Serine phosphorylation of cortactin promotes actin assem-
bly in cells. Serine phosphorylation of cortactin has been
reported to stimulate N-WASP-Arp2/3-mediated actin poly-
merization in vitro, and this stimulatory effect was prevented
by subsequent tyrosine phosphorylation (18). More recently,
another in vitro study using purified components demonstrated
that tyrosine phosphorylation of cortactin does amplify the
generation of actin barbed ends; however, this effect requires
the adaptor protein Nck1 as an additional component of the
actin assembly mixture. In addition, it is further enhanced by
including WASP-interacting protein (WIP) (28). These latter
components were not included in the earlier study. Our primary
goal was to provide a useful extension of these in vitro
observations to the context of living cells, something that has
been lacking to date. To this end, we analyzed the effects of
different cortactin phospho-mutants on the number, length, and
girth of PIP5K1-induced actin comet tails as an in vivo
indicator of the assembly of actin networks. Indeed, our ob-
servations of a marked increase in comet numbers and dimen-
sions in cells expressing CortSD are in strong support of the
observations made in vitro. However, an increase in comet
length was also observed in cells expressing CortWT and
CortYE, indicating a complex interplay of cortactin phosphor-
ylation in the regulation of actin dynamics within cells. Inter-
estingly, unusually wide, bifurcated comets were observed at
the light microscopy level in CortSD-expressing cells (Fig.
3D), and using electron microscopy, a wide base of actin
nucleation that appeared to wrap around more than half of the
vesicle membrane could be detected at the membrane interface.
Such robust actin branching would be particularly useful at the
leading edge of a migrating tumor cell to extend a lamellipo-
dium forward.
Cortactin as a key regulator of focal adhesion dynamics?
Cortactin has been implicated in the regulation of focal adhe-
sion dynamics in migrating cells (1). Because expression of
CortYE did not appear to alter actin assembly appreciably
in vivo (Fig. 3) and Src-mediated phosphorylation is known to
play a key role in regulating focal adhesion dynamics (8, 34),
we tested whether tyrosine phosphorylation of cortactin may
preferentially affect focal adhesion size and/or dynamics (Figs.
4 and 5). Here, we observed a marked increase in the size of
focal adhesions in cells expressing either CortWT or CortYF,
consistent with observations of others that cortactin promotes
focal adhesion stability (1). Moreover, the marked increase in
Fig. 6. Cortactin localizes to focal adhesions situated at the end of large actin
stress fibers. A–B: fluorescence images of fibroblasts expressing RFP-tagged
CortWT (A and B) and stained for actin (rhodamine-phalloidin, A) or paxillin
(B). In addition to a prominent localization to lamellipodia and the Golgi,
numerous cortactin-positive adhesion-like plaques (A, arrows) can be seen
oriented lengthwise throughout the cytoplasm, which coalign with the tips of
large actin fibers (A, arrows). The significant overlap with paxillin staining
(B, arrows) indicates that this cortactin localization represents focal adhesions.
G, Golgi; N, nucleus. C: cartoon depicting how distinct types of cortactin
phosphorylation, ERK-mediated serine phosphorylation, and Src-mediated
tyrosine phosphorylation could influence cell migration. Phosphorylation of
cortactin on serine residues by ERK may promote the formation of dendritic
branched actin networks that support lamellipodial extension. In contrast,
Src-mediated tyrosine phosphorylation of cortactin appears to predominantly
affect focal adhesion dynamics, resulting in increased focal adhesion turnover
and a subsequent decrease in adhesion and stress fiber size.
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the size of focal adhesions in cells expressing CortYF (Fig. 4)
suggests a role for cortactin tyrosine phosphorylation in focal
adhesion disassembly. Indeed, observation of GFP-paxillin in
living cells (Fig. 4) using TIRF microscopy revealed a sub-
stantial difference in focal adhesion turnover in cells express-
ing CortYE (turnover in 5–15 min) versus CortWT (turnover in
15–25 min) or CortYF (stable25 min). Results from an assay
using a distinct approach to measure focal adhesion dynamics—
the ability of focal adhesions to reassemble following micro-
tubule-mediated disassembly—provided further support to
these findings (Fig. 5).
All of these observations are consistent with an important
role for cortactin phosphorylation in regulating focal adhesion
dynamics, and in turn, lamellipodial protrusion. Furthermore,
our findings are consistent with the premise that active Src
(favoring tyrosine-phosphorylated cortactin and corresponding
to CortYE) leads to smaller focal adhesions (8). Conversely,
cells lacking Src family kinases or expressing a kinase-dead
Src (corresponding to CortYF) have enlarged peripheral focal
adhesions with impaired disassembly (8, 13, 33). Thus, Src-
mediated phosphorylation of cortactin may be important in
regulating focal adhesion size and dynamics, and thereby
modulate cell migration.
As illustrated in Fig. 6C, we propose that differential cor-
tactin phosphorylation plays an important role in the regulation
of two distinct processes, actin and focal adhesion dynamics,
both of which can contribute to cell migration. How these
processes are affected by differences in the phosphorylation
status of cortactin is unclear, although alterations in protein-
protein interactions are likely to be involved. For example,
serine phosphorylation of cortactin by ERK appears to allow
for an increased association with N-WASP and facilitate
branched actin assembly (18), whereas tyrosine phosphoryla-
tion of cortactin increases its association not only with Nck1
(28), but also with dynamin (37), an interaction which might
contribute to focal adhesion disassembly (7). Based on the
findings described here, in combination with those from other
groups (1, 18, 28), we predict that phospho-regulation of
cortactin contributes to cell motility in two major ways. First,
serine phosphorylation by ERK promotes the formation of
branched actin networks, which supports lamellipodial forma-
tion and extension. Second, tyrosine phosphorylation by Src
may also promote some actin assembly in vivo, although most
conspicuously triggers turnover of focal adhesions and a re-
duction in the capping or anchoring of actin stress fibers at
these structures.
In the future it will be important to determine how the
specific phospho-forms of cortactin are regulated by different
cellular stimulations, the interplay among the various types of
cortactin phosphorylation, and the distinct effects of the vari-
ous cortactin phospho-forms on the variety of cellular pro-
cesses involving cortactin.
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